Using 330 and 484 subjects with and without Aβ-related pathology, such as cognitive impairment, the researchers analyzed whether BIN1 methylation levels in peripheral blood were associated with susceptibility AD and with early-stage changes in LOAD cerebrospinal fluid (CSF). Here, BIN1 is linked to Alzheimer disease.